In addition, the results of the current study indicated that the hepatic level of smad-7 was significantly reduced by 58.0%, whereas hepatic levels of smad-3 and collagen a1 were raised by 4.5- and 6.3-fold, respectively in the liver fibrosis group compared to the control group. This evidence concerns the gene SMAD3 and Hepatic fibrosis.